The heterodimerization domains of MLL—FYRN and FYRC—are potential target structures in t(4;11) leukemia

The AF4{middle dot}MLL fusion protein is capable of inducing ALL in mice without requirement of MLL{middle dot}AF4

(2010) A. Bursen et al.   BLOOD

The leukemogenic AF4–MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures

(2010) A Benedikt et al.   LEUKEMIA

The structure of the FYR domain of transforming growth factor beta regulator 1

(2010) María M. García-Alai et al.   PROTEIN SCIENCE

New insights to the MLL recombinome of acute leukemias

(2009) C Meyer et al.   LEUKEMIA

P-TEFb- the final frontier

(2009) Jiri Kohoutek   Cell Division

H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias

(2008) Andrei V. Krivtsov et al.   CANCER CELL